Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Gem

Clinically Approved Ion Channel Inhibitors Close Gates for Hepatitis C Virus and Open Doors for Drug Repurposing in Infectious Viral Diseases

Thomas Pietschmann
Michaela Ulrike Gack, Editor
Thomas Pietschmann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michaela Ulrike Gack
Harvard Medical School
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JVI.01914-16
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1128/JVI.01914-16
PubMed 
27807238

Published By 
American Society for Microbiology Journals
History 
  • Published online January 3, 2017.

Copyright & Usage 
Copyright © 2017 American Society for Microbiology. All Rights Reserved .
Editors and / or Reviewers 
  • Michaela Ulrike Gack, Editor, Harvard Medical School

Article Versions

  • Accepted Manuscript version (November 02, 2016).
  • You are viewing the most recent version of this article.

Author Information

  1. Thomas Pietschmann
  1. Institute for Experimental Virology, TWINCORE Centre for Experimental and Clinical Infection Research, Hannover, Germany, and German Centre for Infection Research, Hannover-Braunschweig, Germany
  • Address correspondence to thomas.pietschmann{at}twincore.de.
  • Citation Pietschmann T. 2017. Clinically approved ion channel inhibitors close gates for hepatitis C virus and open doors for drug repurposing in infectious viral diseases. J Virol 91:e01914-16. https://doi.org/10.1128/JVI.01914-16 .

Article usage

Article usage: November 2016 to March 2021

Rendering graph...
AbstractFullPdf
Nov 20166240148
Dec 201655260
Jan 20171535404176
Feb 201722142960
Mar 201715266338
Apr 20179358425
May 20178156329
Jun 20175544120
Jul 20173723780
Aug 2017449334
Sep 2017431934
Oct 2017244818
Nov 2017271718
Dec 2017312712
Jan 2018292829
Feb 2018361922
Mar 2018191110
Apr 2018342327
May 2018301916
Jun 2018242018
Jul 201881713
Aug 2018142115
Sep 201822711
Oct 201834019
Nov 201872724
Dec 201842621
Jan 201932011
Feb 201933126
Mar 2019103724
Apr 201943028
May 201939616
Jun 201923831
Jul 201913218
Aug 20192408
Sep 201915013
Oct 201932612
Nov 201923834
Dec 201922720
Jan 202014813
Feb 202043312
Mar 202018529
Apr 2020117732
May 202077919
Jun 202043824
Jul 202003010
Aug 202042519
Sep 20207238
Oct 202073524
Nov 202093620
Dec 20204329
Jan 202123112
Feb 20211137
Mar 2021133
PreviousNext
Back to top
Download PDF
Citation Tools
Clinically Approved Ion Channel Inhibitors Close Gates for Hepatitis C Virus and Open Doors for Drug Repurposing in Infectious Viral Diseases
Thomas Pietschmann
Journal of Virology Jan 2017, 91 (2) e01914-16; DOI: 10.1128/JVI.01914-16

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Clinically Approved Ion Channel Inhibitors Close Gates for Hepatitis C Virus and Open Doors for Drug Repurposing in Infectious Viral Diseases
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Clinically Approved Ion Channel Inhibitors Close Gates for Hepatitis C Virus and Open Doors for Drug Repurposing in Infectious Viral Diseases
Thomas Pietschmann
Journal of Virology Jan 2017, 91 (2) e01914-16; DOI: 10.1128/JVI.01914-16
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • HCV AND HEPATITIS C: FROM THE UNKNOWN CULPRIT TO THE FIRST CURABLE CHRONIC VIRAL INFECTION
    • ION CHANNEL INHIBITORS AND RELATED ANTIHISTAMINES AS FIRST-IN-CLASS HCV MEMBRANE FUSION INHIBITORS
    • ACKNOWLEDGMENTS
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

antiviral agents
Drug Repositioning
hepacivirus
Hepatitis C
Ion Channel Gating
Ion Channels
cell entry
drug repurposing
fusion inhibitor
hepatitis C virus
infectious disease
ion channel inhibitors
membrane fusion

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514